Search Results - Pruniaux, M.P.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Alirocumab decreases plasma Lp(a) levels without enhancing Lp(a) liver uptake in vivo

    Alirocumab decreases plasma Lp(a) levels without enhancing Lp(a) liver uptake in vivo by Beeske, S., Poirier, B., Villard, E.F., Le Bail, J.C., Dargazanli, G., Tran, T.T.T., Ho-Van Guimbal, S., Bayard, A., Tirode, F., Boulay, D., Bergis, O., Lambert, G., Pruniaux, M.P., Janiak, P., Guillot, E.

    Published in Atherosclerosis
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Generation of iPSC line from MYH7 R403L mutation carrier with HCM and isogenic CRISPR/Cas9 corrected control

    Generation of iPSC line from MYH7 R403L mutation carrier with HCM and isogenic CRISPR/Cas9 corrected control by Fontaine, V., Duboscq-Bidot, L., Jouve, C., Hamlin, M., Curjol, A., Briand, V., Janiak, P., Hulot, J., Pruniaux-Harnist, M.P., Charron, P., Villard, E.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-α production in whole blood from COPD patients

    The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-α production in whole blood from COPD patients by Ouagued, M., Martin-Chouly, C.A.E., Brinchault, G., Leportier-Comoy, C., Depincé, A., Bertrand, C., Lagente, V., Belleguic, C., Pruniaux, M.P.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: